EKF Diagnostics (OTCMKTS:EKDHF) Stock Rating Lowered by Investec

EKF Diagnostics (OTCMKTS:EKDHFGet Free Report) was downgraded by Investec from a “buy” rating to a “hold” rating in a research note issued on Friday, FlyOnTheWall reports.

EKF Diagnostics Price Performance

EKF Diagnostics stock opened at $0.31 on Friday. The firm has a 50 day simple moving average of $0.31 and a 200-day simple moving average of $0.32. EKF Diagnostics has a 1-year low of $0.31 and a 1-year high of $0.31.

About EKF Diagnostics

(Get Free Report)

EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.

See Also

Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.